Net Cash Provided by (Used in) Financing Activities in USD of Peak Bio, Inc. from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Peak Bio, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from Q1 2021 to Q1 2024.
  • Peak Bio, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was $1.11M, a 3.17% decline year-over-year.
  • Peak Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $4.28M, a 47.4% decline from 2022.
  • Peak Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $8.14M, a 2.98% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Peak Bio, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.11M -$36.3K -3.17% 01 Jan 2024 31 Mar 2024 10-Q 23 Aug 2024
Q1 2023 $1.14M -$106K -8.49% 01 Jan 2023 31 Mar 2023 10-Q 23 Aug 2024
Q1 2022 $1.25M -$57.2M -97.9% 01 Jan 2022 31 Mar 2022 10-Q 12 Jul 2023
Q1 2021 $58.5M 01 Jan 2021 31 Mar 2021 10-Q 19 May 2022

Peak Bio, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.28M -$3.85M -47.4% 01 Jan 2023 31 Dec 2023 10-K 06 Aug 2024
2022 $8.14M -$250K -2.98% 01 Jan 2022 31 Dec 2022 10-K 06 Aug 2024
2021 $8.39M 01 Jan 2021 31 Dec 2021 10-K 29 Jun 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.